Ming Vision's First Domestic Trifocal Intraocular Lens, VisionQ Extreme®, Launches in China

Recently,Qiming Venture Capital's portfolio company, Vision Pro, has launched its first domestically produced trifocal intraocular lens, "Shiquanji®", which has garnered significant attention in the ophthalmology field both in China and internationally. The product launch seminar was held in Wuhan, Hubei, marking the beginning of a new era for high-end, Chinese-made trifocal intraocular lenses.

The trifocal intraocular lens is a typical representative of high-end intraocular lenses. Previously, there has not been a truly Chinese-produced trifocal intraocular lens available in the market, with constraints mainly lying in material design, optical design, product registration, and other aspects. After years of research and development, clinical trials, and registration procedures, Vision Pro's "Shiquanji®" has finally succeeded in entering the market, truly becoming the first Chinese-produced trifocal intraocular lens.

At the beginning of the meeting,Dr. Liao Xiugao, Chairman and General Manager and founder of Vision Pro, introduced the launch of "Shiquanji®", which marks that the self-research and production capability of high-end trifocal intraocular lenses made in China has reached a new height. This achievement embodies the hard work and wisdom of countless researchers.In terms of material design, optical design, and product registration, Vision Pro overcame numerous challenges to ultimately achieve a breakthrough from 0 to 1. "VisionMax®" provides continuous and smooth visual transitions, which traditional monofocal or bifocal intraocular lenses cannot match. Dr. Liao Xiugao and his fellow ophthalmologists are looking forward to "VisionMax®" bringing new breakthroughs and a bright future to the field of ophthalmic medicine. In addition,Vision Pro is actively expanding its product lines for myopia prevention and control among teenagers and consumer medical products, and will continue to provide excellent products covering multiple fields.

Dr. Liao Xiugao, Chairman and General Manager of Vision Pro, Founder

Professor Li Xuemin from the Third Hospital of Peking University, as one of the Phase 3 clinical experts for the "Vision Pro®" trifocal intraocular lens, provided a detailed interpretation for the audience based on personal experience and rigorous clinical data.Traditional trifocal intraocular lenses have significant drawbacks, such as noticeable decline in intermediate vision, visual discontinuity between focal points, prominent visual disturbances, and especially night glare."VisionPro®" breaks through the design concept of traditional trifocal lenses, incorporating three national invention patents: "SS" smooth phase modulation structure, axial progressive design, and achromatic structure. Clinical research results from Phase III studies have confirmed that "VisionPro®" can provide clear and continuous dynamic vision at far, intermediate, and near distances, with particularly excellent performance in intermediate vision.Whether it's outdoor activities, indoor living, reading, or painting, a seamless and uninterrupted field of vision can be achieved across multiple scenarios."VisionPro®" unique design to reduce diffraction ring sharpness results in significantly less glare compared to other diffractive multifocal lenses, providing patients with a more comfortable visual experience and fewer glare issues, allowing them to truly enjoy a worry-free, high-quality life.

Source | International Ophthalmology Times